• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“银屑灵”(Ro 10 - 9359)对人体血清脂蛋白的影响。

The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man.

作者信息

Michaëlsson G, Bergqvist A, Vahlquist A, Vessby B

出版信息

Br J Dermatol. 1981 Aug;105(2):201-5. doi: 10.1111/j.1365-2133.1981.tb01206.x.

DOI:10.1111/j.1365-2133.1981.tb01206.x
PMID:7284249
Abstract

Eight patients with psoriasis or Darier's disease were studied during 1-3 months of 'Tigason' treatment (0.7-0.8 mg/kg body weight). The levels of triglycerides and cholesterol in whole serum and in different lipoprotein fractions were repeatedly determined. Before treatment all lipid values were within the normal range. During treatment the values changed gradually and five of the eight patients developed pathological VLDL triglyceride concentrations. A significant increase of VLDL cholesterol and a decrease in the HDL cholesterol was also noted. Until more information is available, prolonged treatment periods with 'Tigason' should perhaps be avoided, at least in high risk patients.

摘要

八名患有银屑病或毛囊角化病的患者在接受1至3个月的“银屑灵”治疗(0.7至0.8毫克/千克体重)期间接受了研究。对全血清和不同脂蛋白组分中的甘油三酯和胆固醇水平进行了反复测定。治疗前,所有血脂值均在正常范围内。治疗期间,这些值逐渐变化,八名患者中有五名出现了病理性极低密度脂蛋白甘油三酯浓度。还注意到极低密度脂蛋白胆固醇显著增加,高密度脂蛋白胆固醇降低。在获得更多信息之前,或许应避免长期使用“银屑灵”进行治疗,至少对于高危患者应如此。

相似文献

1
The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man.“银屑灵”(Ro 10 - 9359)对人体血清脂蛋白的影响。
Br J Dermatol. 1981 Aug;105(2):201-5. doi: 10.1111/j.1365-2133.1981.tb01206.x.
2
The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
Br J Dermatol. 1981 Jun;104(6):675-9. doi: 10.1111/j.1365-2133.1981.tb00754.x.
3
Etretinate therapy causes increases in lipid levels in patients with psoriasis.依曲替酯疗法会使银屑病患者的血脂水平升高。
Arch Dermatol. 1982 Aug;118(8):559-62.
4
Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).用维甲酸衍生物Ro 10-9359(替加松)治疗毛囊角化病(达里埃病)
Dermatologica. 1981;163(2):164-8.
5
Etretinate: effect of milk intake on absorption.依曲替酯:牛奶摄入对其吸收的影响。
J Invest Dermatol. 1984 Jun;82(6):636-40. doi: 10.1111/1523-1747.ep12261476.
6
Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
N Z Med J. 1981 Aug 12;94(689):99-100.
7
Effects of etretinate (Ro 10-9359) on Darier's Disease.
Dermatologica. 1982 Aug;165(2):123-30. doi: 10.1159/000249930.
8
Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier's disease.
Acta Derm Venereol. 1982;62(3):267-8.
9
Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.一种芳香维甲酸(依曲替酯)对银屑病和毛囊角化病的临床、超微结构及生化效应
Acta Derm Venereol Suppl (Stockh). 1982;101:1-29.
10
[Changes in serum lipid fractions as a side effect of oral retinoids].
Z Hautkr. 1982 Sep 1;57(17):1255-67.

引用本文的文献

1
Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.依曲替酯。对其药理特性及在银屑病和其他皮肤病中的治疗效果的综述。
Drugs. 1983 Jul;26(1):9-43. doi: 10.2165/00003495-198326010-00002.
2
The retinoids. A review of their clinical pharmacology and therapeutic use.维甲酸类药物。其临床药理学与治疗应用综述。
Drugs. 1987 Oct;34(4):459-503. doi: 10.2165/00003495-198734040-00003.